Florida Cancer Specialists & Research Institute, LLC (FCS) medical oncologists and hematologists are contributors to groundbreaking breast cancer research studies being presented this week at the San ...
Reallocates Resources to Metabolic Program and Discontinues Enrollment in Phase 1 Study of BP1002 to Treat Relapsed/Refractory Lymphoma and Relapsed/Refractory Chronic Lymphocytic Leukemia Due to ...
Data from the ongoing Phase 2 of EO4010 demonstrate tumor target specific immune responses and objective tumor responses, including in liver mets, in patients with previously treated microsatellite ...